Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies

Samankaltaisia teoksia

• Long-term safety, tolerability and efficacy of galantamine: Results from a 36-month analysis of extension study data
  Tekijä: Wilcock, G, et al.
  Julkaistu: (2002)
• Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
  Tekijä: Pirttilä, T, et al.
  Julkaistu: (2004)
• Galantamine in Alzheimer's disease.
  Tekijä: Razay, G, et al.
  Julkaistu: (2008)
• A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
  Tekijä: Wilcock, G, et al.
  Julkaistu: (2003)
• Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
  Tekijä: Wilcock, G, et al.
  Julkaistu: (2000)